Anabolic steroid abuse: Physiological and anaesthetic considerations

Anaesthesia

Volumn 60, Issue 7, 2005, Pages 685-692

  Kam, P C A ^a   Yarrow, M ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ANABOLIC AGENT; ANESTHETIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOLDENONE; CLENBUTEROL; CREATINE; DANAZOL; DIURETIC AGENT; DROSTANOLONE; EPHEDRINE; ETHYLESTRENOL; FLUOXYMESTERONE; HUMAN GROWTH HORMONE; INSULIN; METANDIENONE; METENOLONE; METHANDRIOL; METHYLTESTOSTERONE; NANDROLONE; NANDROLONE DERIVATIVE; NANDROLONE PHENPROPIONATE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; OXANDROLONE; OXYMETHOLONE; SOMATOMEDIN; STANOZOLOL; SUXAMETHONIUM; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE DERIVATIVE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE PROPIONATE; TETRAHYDROGESTRINONE; THYROXINE; TRENBOLONE;

ABSCESS; ACNE; ALOPECIA; ANOVULATION; ANTISOCIAL BEHAVIOR; ATHEROSCLEROSIS; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; BEHAVIOR DISORDER; CALCIFICATION; CARDIOMYOPATHY; CHOLESTASIS; CORONARY ARTERY SPASM; DOPING; DRUG ABUSE; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DYSLIPIDEMIA; DYSTROPHY; ELECTROLYTE DISTURBANCE; FEMALE INFERTILITY; GRANULOMA; GROWTH RETARDATION; GYNECOMASTIA; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEPATITIS B; HEPATITIS C; HIRSUTISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPOMANIA; INJECTION SITE REACTION; KIDNEY CANCER; LIBIDO DISORDER; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER HEMATOMA; LIVER TOXICITY; MALE INFERTILITY; MANIA; MENSTRUATION DISORDER; MENTAL DISEASE; MOOD DISORDER; MUSCLE GROWTH; PELIOSIS HEPATIS; PERIOPERATIVE PERIOD; POLYCYTHEMIA; PROTEIN SYNTHESIS; REVIEW; RISK ASSESSMENT; SEPTICEMIA; SKIN FIBROSIS; SKIN MANIFESTATION; SUDDEN DEATH; TENDON RUPTURE; TESTIS ATROPHY; TESTIS TUMOR; THROMBOSIS; VIOLENCE; VIRILIZATION; WITHDRAWAL SYNDROME;

ANABOLIC AGENTS; ANESTHESIA; CARDIOVASCULAR DISEASES; DOPING IN SPORTS; DRUG INTERACTIONS; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 21344436444     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2005.04218.x     Document Type: Review

References (66)

1. Ferner RE, Rawlins MD. Anabolic steroids. The Power and the Glory? British Medical Journal 1988; 297: 877-8.
2. Yesalis C, Wright J, Lombardo J. Anabolic-androgenic steroids: a synthesis of existing data and recommendations for further research. Clinical Sports Medicine 1989; 1: 109-34.
3. Mottram DR, George AJ. Anabolic steroids. Baillieres Best Practice & Research: Clinical Endocrinology and Metabolism 2000; 14: 55-69.
4. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic Government. Clinical Chemistry 1997; 43: 1262-79.
5. Loughton SJ, Ruhling RO. Human strength and endurance responses to anabolic steroids and training. Journal of Sports Medicine 1977; 17: 285.
6. Schanzer W. Metabolism of anabolic androgenic steroids. Clinical Chemistry 1996; 42: 1001-20.
7. Perry HM, Wright D, Littlepage BNC. Dying to be big: a review of anabolic steroid use. British Journal of Sports Medicine 1992; 26: 259-61.
8. Bolding G, Sherr L, Elford J. Use of anabolic steroids and associated health risks among gay men attending London gyrus. Addiction 2002; 97: 195-203.
9. Korkia P. Use of anabolic steroids has been reported by 9% of men attending gymnasiums. British Medical Journal 1996; 313: 1009.
10. Buckley WE, Yesalis CE, Friedl KE. Estimated prevalence of anabolic steroid use among male high school seniors. Journal of American Medical Association 1988; 260: 3441-5.
11. Evans NA. Current concepts in anabolic-androgenic steroids. American Journal of Sports Medicine 2004; 32: 534-42.
12. Dawson RT. Drugs in sport - the role of the physician. Journal of Endocrinology 2001; 170: 55-61.
13. Lubahn DB, Joseph DR, Sullivan PM. Cloning of the human androgen receptor complementary DNA and localisation to the X chromosome. Science 1988; 240: 327-30.
14. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Progress in Cardiovascular Diseases 1998; 41: 1-15.
15. Wu FCW. Endocrine aspects of anabolic steroids. Clinical Chemistry 1997; 43: 1289-92.
16. Seene T, Viru A. The catabolic effect of glucocorticoids on different types of skeletal muscle fibres and its dependence upon muscle activity and interaction with anabolic steroids. Journal of Steroid Biochemistry 1982; 16: 349-52.
17. Danhaive PA, Rousseau GG. Evidence for sex dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat. Journal of Steroid Biochemistry 1988; 29: 575-81.
18. Montuschi E. The newer steroids. British Medical Journal 1959; 1: 647-8.
19. Kuhn CM. Anabolic steroids. Recent Progress in Hormone Research 2002; 57: 411-34.
20. Bartsch W. Anabolic steroids - action on a cellular level. Wiener Medizinische Wochenschrift 1993; 143: 363-6.
21. Death AK, McGrath KCY, Kazlauskas K, Handelsman DJ. Tetrahydrogestrinone is a potent androgen and progestin. Journal of Clinical Endocrinology and Metabolism 2004; 89: 2498-500.
22. Strauss KH, Yesalis CE. Anabolic steroids in the athlete. Annual Reviews in Medicine 1991; 42: 449-57.
23. O'Sullivan AJ. Anabolic-androgenic steroids: medical assessment of present, past and potential users. Medical Journal of Australia 2000; 173: 323-7.
24. Strauss RH, Liggett MT, Lanese RK. Anabolic steroid use and perceived effects in ten weight trained women athletes. Journal of American Medical Association 1985; 253: 2871-3.
25. Dickerman RD, Schaller F, Prather I. Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 1995; 86: 172-3.
26. Kennedy MC, Lawrence C. Anabolic steroid abuse and cardiac death. Medical Journal of Australia 1993; 158: 346-8.
27. Luke JL, Farb A, Virmani R. Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: Pathological and toxicological findings. Journal of Forensic Sciences 1990; 35: 1441-7.
28. Fineschi V, Baroldi G, Monciotti F. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Archives of Pathology and Laboratory Medicine 2001; 125: 253-5.
29. Kennedy MC, Corrigan AB, Pilbeam ST. Myocardial infarction and cerebral haemorrhage in a young body builder taking anabolic steroids. Australia and New Zealand Journal of Medicine 1993; 23: 713.
30. Nieminen MS, Ramo MP, Viitasalo M. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. European Heart Journal 1996; 17: 1576-83.
31. De Piccoli B, Giada F, Benettin A. Anabolic steroid use in body builders: an echocardiographic study of left ventricular morphology and function. International Journal of Sports Medicine 1991; 12: 408-12.
32. Sachtleben TR, Berg KE, Elias BA. The effects of anabolic steroids on myocardial structure and cardiovascular fitness. Medicine and Science in Sports and Exercise 1993; 25: 1240-5.
33. Salke RC, Rowland TW, Burke EJ. Left ventricular size and function in body builders using anabolic steroids. Medicine and Science in Sports and Exercise 1985; 17: 701-4.
34. Lyndberg KK. Myocardial and death of a body builder after using anabolic steroids. Ugersk Laeger 1991; 153: 587-8.
35. Melchert RB, Herron TJ, Welder AA. The effect of anabolic-androgenic steroids on primary myocardial cell cultures. Medicine and Science in Sports and Exercise 1992; 24: 206-12.
36. Baker PJ, Ramey ER, Ramwell PW. Androgen mediated sex differences of cardiovascular responses in rats. American Journal of Physiology 1978; 235: H 242-6.
37. Dickerman RD, McConathy WJ, Zachariah NY. Testosterone, sex hormone-binding globulin, lipoproteins and vascular disease risk. Journal of Cardiovascular Risk 1997; 4: 363-6.
38. Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Archives of International Medicine 1991; 151: 1925-33.
39. McNutt RA, Ferenchick GS, Kirlin PC. Acute myocardial infarction in a 22 year old world class weight lifter using anabolic steroids. American Journal of Cardiology 1988; 62: 164.
40. Ferenchick GS. Are androgenic steroids thrombogenic? New England Journal of Medicine 1990; 322: 476.
41. Frankle MA, Eichberg R, Zachariah SB. Anabolic androgenic steroids and a stroke in an athlete: case report. Archives of Physical Medicine and Rehabilitation 1988; 69: 632-3.
42. Falkenberg M, Karlsson J, Ortenwall P. Peripheral arterial thrombosis in two young men using anabolic steroids. European Journal of Vascular and Endovascular Surgery 1997; 13: 223-6.
43. McCarthy K, Tang AT, Dalrymple-Hay MJ. Ventricular thrombosis and systemic embolism in bodybuilders. Etiology and management. Annals of Thoracic Surgery 2000; 70: 658-60.
44. Ferenchick GS. Anabolic androgenic steroid abuse and thrombosis: is there a connection? Medical Hypotheses 1991; 35: 27-31.
45. Pilo R, Aharony D, Raz A. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic metabolism. Thrombosis and Haemostasis 1981; 46: 538-42.
46. Nakao J, Change WC, Murota SI, Orimo H. Testosterone inhibits prostacyclin production by rat aorta smooth muscle cells in culture. Atherosclerosis 1981; 39: 203-9.
47. Rockhold RW. Cardiovascular toxicity of anabolic steroids. Annual Review of Pharmacology and Toxicology 1993; 33: 497-520.
48. Sader MA, Griffiths KA, McCredie RJ. Androgenic anabolic steroids and arterial structure and function in male bodybuilders. Journal of American College of Cardiologists 2001; 37: 224-30.
49. Ebenbichler CF, Kaser S, Bodner J. Hyperhomocysteinemia in bodybuilders taking anabolic steroids. European Journal of International Medicine 2001; 12: 43-7.
50. Forbes GM, Bramston BA, Collins BJ. Anabolic steroid hepatotoxicity: lessons to be learnt? Australian and New Zealand Journal of Medicine 1993; 23: 309-10.
51. Bagia S, Hewitt PM, Morris DL. Anabolic steroid induced hepatic adenomas with spontaneous haemorrhage in a bodybuilder. Australia and New Zealand Journal of Surgery 2000; 70: 686-7.
52. Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. American Journal of Sports Medicine 1984; 12: 469-84.
53. Schumacher J, Muller G, Klotz KF. Large hepatic haematoma and intraabdominal hemorrhage associated with abuse of anabolic steroids. New England Journal of Medicine 1999; 340: 1123-4.
54. Dickerman RD, Pertusi RM, Zachariah NY. Anabolic steroid induced hepatotoxicity: is it overstated? Clinical Journal of Sports Medicine 1999; 9: 34-9.
55. Graham S, Kennedy M. Recent developments in the toxicology of anabolic steroids. Drug Safety 1990; 5: 458-76.
56. Schwerin MJ, Corcoran KJ. Beliefs about steroids: user versus non-user comparisons. Drug and Alcohol Dependence 1996; 40: 221-5.
57. Su TP, Pagliaro M, Schmidt PJ, Pickar D. Neuropsychiatric effects of anabolic steroids in male normal volunteers. Journal of American Medical Association 1993; 269: 2760-4.
58. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Medicine 2002; 32: 285-96.
59. Corrigan B. Anabolic steroids and the mind. Medical Journal of Australia 1996; 165: 222-6.
60. Alen M, Hakkinen K. Androgenic effects on serum hormones and on maximal force development in strength athletes. Journal of Sports Medicine and Physical Fitness 1987; 27: 38-46.
61. Parssinen M, Seppala T. Steroid use and long term health risks in former athletes. Sports Medicine 2002; 32: 83-94.
62. Sellers WF, Culwick MD, Whiting RF. Anabolic steroids and anaesthesia. Anaesthesia and Intensive Care 1991; 19: 616.
63. Bahia H, Platt A, Hart NB. Anabolic steroid accelerated multicompartment syndrome following trauma. British Journal of Sports Medicine 2000; 34: 308-9.
64. Reddy P, Guzman A, Robalino J. Resistance to muscle relaxants in a patient receiving prolonged testosterone therapy. Anesthesiology 1989; 70: 871-3.
65. Kopera H. Interactions of anabolic steroids. Wiener Medizinische Wochenschrift 1993; 143: 401-2.
66. Medras M, Tworowska U, Jozkow P, Dumanski A, Dubinski A. Post operative course and anabolic-androgenic steroid abuse - a case report. Anaesthesia 2005; 60: 81-4.